Oxford Biomedica Balance Sheet Health
Financial Health criteria checks 4/6
Oxford Biomedica tiene unos fondos propios totales de £198.2M y una deuda total de £38.4M, lo que sitúa su ratio deuda/fondos propios en 19.4%. Sus activos y pasivos totales son £401.1M y £202.9M respectivamente.
Key information
19.4%
Debt to equity ratio
UK£38.44m
Debt
| Interest coverage ratio | n/a |
| Cash | UK£129.43m |
| Equity | UK£198.16m |
| Total liabilities | UK£202.91m |
| Total assets | UK£401.07m |
Recent financial health updates
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?
Oct 19
Is Oxford Biomedica (LON:OXB) Using Too Much Debt?
Oct 06We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn
Jun 29We Think Oxford Biomedica (LON:OXB) Can Easily Afford To Drive Business Growth
Mar 09Oxford Biomedica (LON:OXB) Is In A Good Position To Deliver On Growth Plans
Dec 01
Recent updates
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?
Oct 19Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%
Aug 23Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value
Feb 15Is Oxford Biomedica (LON:OXB) Using Too Much Debt?
Oct 06Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings
May 02We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn
Jun 29We Think Oxford Biomedica (LON:OXB) Can Easily Afford To Drive Business Growth
Mar 09What Kind Of Shareholders Own Oxford Biomedica plc (LON:OXB)?
Feb 08Investors Who Bought Oxford Biomedica (LON:OXB) Shares Five Years Ago Are Now Up 202%
Dec 24The Independent Non-Executive Director of Oxford Biomedica plc (LON:OXB), Andrew John Heath, Just Sold 79% Of Their Holding
Dec 02Oxford Biomedica (LON:OXB) Is In A Good Position To Deliver On Growth Plans
Dec 01Financial Position Analysis
Pasivos a corto plazo: OXBLos activos a corto plazo (£177.7M) de la empresa superan a sus pasivos a corto plazo (£53.5M).
Pasivo a largo plazo: OXBLos activos a corto plazo (£177.7M) superan a sus pasivos a largo plazo (£149.4M).
Debt to Equity History and Analysis
Nivel de deuda: OXB tiene más efectivo que su deuda total.
Reducción de la deuda: OXB ha pasado de 124.1% a 19.4% en los últimos 5 años.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Cash runway estable: Datos insuficientes para determinar si OXB tiene suficiente margen de liquidez basado en su flujo de caja libre actual.
Pronóstico de cash runway: Datos insuficientes para determinar si OXB tiene suficiente margen de liquidez en caso de que su flujo de caja libre siga creciendo o disminuyendo en función de las tasas históricas.